1. Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients. (February 2020) Authors: Reale, Maria Lucia; Chiari, Rita; Tiseo, Marcello; Vitiello, Fabiana; Barbieri, Fausto; Cortinovis, Diego; Ceresoli, Giovanni Luca; Finocchiaro, Giovanna; Romano, Gianpiero Diego; Piovano, Pier Luigi; Del Conte, Alessandro; Borra, Gloria; Verderame, Francesco; Scotti, Vieri; Nonnis, Daniela; Gale... Journal: Lung cancer Issue: Volume 140(2020) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brigatinib as a treatment of ALK-positive non-small cell lung cancer. Issue 5 (3rd September 2021) Authors: De Carlo, Elisa; Stanzione, Brigida; Del Conte, Alessandro; Revelant, Alberto; Bearz, Alessandra Journal: Expert review of precision medicine and drug development Issue: Volume 6:Issue 5(2021) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cyclophosphamide with or without fluorouracil followed by subcutaneous or intravenous interleukin-2 use in solid tumors: A feasibility off-label experience. (January 2019) Authors: Lo Re, Giovanni; Lo Re, Francesco; Doretto, Paolo; Del Conte, Alessandro; Amadio, Maria; Cozzi, Cinzia; Casarotto, Maria Maddalena; Maruzzi, Daniele; Marus, Wally; Ubiali, Paolo; Sandri, Paolo Journal: Cytokine Issue: Volume 113(2019) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences. (October 2022) Authors: Tabbò, Fabrizio; Muscarella, Lucia Anna; Gobbini, Elisa; Trombetta, Domenico; Castellana, Stefano; Rigutto, Angelica; Galetta, Domenico; Maiello, Evaristo; Martelli, Olga; Tiseo, Marcello; Scotti, Vieri; Ghilardi, Laura; Gregorc, Vanesa; Sergi, Concetta; Pilotto, Sara; Del Conte, Alessandro; Capp... Journal: European journal of cancer Issue: Volume 174(2022) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer. (September 2016) Authors: Cappuzzo, Federico; Morabito, Alessandro; Normanno, Nicola; Bidoli, Paolo; Del Conte, Alessandro; Giannetta, Laura; Montanino, Agnese; Mazzoni, Francesca; Buosi, Roberta; Burgio, Marco Angelo; Cerea, Giulio; Chiari, Rita; Cortinovis, Diego; Finocchiaro, Giovanna; Foltran, Luisa; Migliorino, Maria... Journal: Lung cancer Issue: Volume 99(2016) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial. (August 2019) Authors: Capelletto, Enrica; Migliorino, Maria Rita; Morabito, Alessandro; Chiari, Rita; Grossi, Francesco; Tiseo, Marcello; Costanzo, Francesco Di; Delmonte, Angelo; Romano, Gianpiero; Galetta, Domenico; Scotti, Vieri; Gregorc, Vanesa; Pisconti, Salvatore; Ceresoli, Giovanni Luca; Del Conte, Alessandro; ... Journal: Lung cancer Issue: Volume 134(2019) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study. (23rd August 2021) Authors: Lorenzi, Martina; Ferro, Alessandra; Cecere, Fabiana; Scattolin, Daniela; Del Conte, Alessandro; Follador, Alessandro; Pilotto, Sara; Polo, Valentina; Santarpia, Mariacarmela; Chiari, Rita; Pavan, Alberto; Dal Maso, Alessandro; Da Ros, Valentina; Targato, Giada; Vari, Sabrina; Indraccolo, Stefano... Journal: Oncologist Issue: Volume 27:Number 2(2022) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status. (May 2020) Authors: Facchinetti, Francesco; Mazzaschi, Giulia; Barbieri, Fausto; Passiglia, Francesco; Mazzoni, Francesca; Berardi, Rossana; Proto, Claudia; Cecere, Fabiana Letizia; Pilotto, Sara; Scotti, Vieri; Rossi, Sabrina; Del Conte, Alessandro; Vita, Emanuele; Bennati, Chiara; Ardizzoni, Andrea; Cerea, Giulio;... Journal: European journal of cancer Issue: Volume 130(2020) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development. (February 2016) Authors: Cazzaniga, Marina E; Camerini, Andrea; Addeo, Raffaele; Nolè, Franco; Munzone, Elisabetta; Collovà, Elena; Del Conte, Alessandro; Mencoboni, Manlio; Papaldo, Paola; Pasini, Felice; Saracchini, Silvana; Bocci, Guido Journal: Future oncology Issue: Volume 12:Number 3(2016) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial. (June 2019) Authors: Platania, Marco; Pasini, Felice; Porcu, Luca; Boeri, Mattia; Verderame, Francesco; Modena, Yasmina; Del Conte, Alessandro; Nichetti, Federico; Garassino, Marina Chiara; Martinetti, Antonia; Sottotetti, Elisa; Cavanna, Luigi; Vattemi, Emanuela; Pozzessere, Daniele; Bertolini, Alessandro; Irtelli, ... Journal: Lung cancer Issue: Volume 132(2019) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗